KAMIN PETER H 13D and 13G filings for Interpace Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-01 10:15 am Unchanged |
2022-01-28 | 13D | Interpace Biosciences, Inc. IDXG |
KAMIN PETER H | 781,956 18.600% |
0 (Unchanged) |
Filing |
| 2022-01-13 08:30 am Unchanged |
2022-01-12 | 13D | Interpace Biosciences, Inc. IDXG |
KAMIN PETER H | 781,956 18.600% |
0 (Unchanged) |
Filing |
| 2021-12-06 4:32 pm Unchanged |
2021-12-03 | 13D | Interpace Biosciences, Inc. IDXG |
KAMIN PETER H | 781,956 18.700% |
0 (Unchanged) |
Filing |
| 2021-03-01 4:06 pm Purchase |
2021-02-18 | 13D | Interpace Biosciences, Inc. IDXG |
KAMIN PETER H | 781,956 19.300% |
781,956 (New Position) |
Filing |